Kocabayoglu P, Friedman S L. Cellular basis of hepatic fibro-sis and its role in inflammation and cancer [J]. Front Biosci (Schol Ed), 2013.217.
|
Zhao J, Zhao Y, Wang H. Association between meta-bolic abnormalities and HBV related hepatocelluar carcinoma in Chinese:a cross-sectional study [J]. NUTRITION JOURNAL, 2011.49.
|
Woo S M, Park J W, Lee W J. Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma pa-tients with chronic hepatitis B [J]. Gut Liver, 2011(1):82.
|
Ottone A, Bellini E, Ferrero A. A case of long-term survival after repeated response to oxaliplatin-based chemo-therapy and repeated thermoablation of liver metastases from colorectal cancer.Should we introduce the concept of oxali-platin-resistant tumors [J]. TUMORI, 2013(3):91e.
|
Park S G, Chung C H, Park C Y. Colon perforat ion during sorafenib therapy for advanced hepatocelluar carcinoma.A case report [J]. TUMORI, 2011(6):794.
|
Ryu H S, Lee K, Shin E. Comparative analysis of im-munohistochemical markers for differential diagnosis of hepa-tocelluar carcinoma and cholangiocarcinoma [J]. TUMORI, 2012(4):478.
|
Xu J, Liu C, Zhou L. Distinctions between clinicopath-ological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients [J]. Asian Pacific Journal of Cancer Prev, 2012(2):559.
|
Li M, Gerber D A, Koruda M. Hepatocelluar carcino-ma associated with attenuated familial adenomatous polyposis:a case report and review of the literature [J]. Clin Colorectal Cancer, 2012(1):77.
|
Huo L, Dang Y, Feng R. Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging [J]. CLINICAL NUCLEAR MEDICINE, 2012(4):393.
|
Yao Y, Li J, Lu Z. Proteomic analysis of the interleu-kin-4 (IL-4)response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15 [J]. Electro-phoresis, 2011, (15):2004.
|
Sheng-Long Y. Asia-pacific primary liver cancer expert meet-ings [J]. Liver cancer, 2012(2):61.
|